HOW DOES A DRUG GET DEVELOPED?

DISCONTINUED: Stages of Development for Acetyl-L-Carnitine (ALCAR)

The drug development process can be thought of as a series of stages, and drugs must successfully pass through each stage to become available to patients. This treatment has been evaluated, and the program has been discontinued. Thus, it is not in the pipeline.

Link to previous study

Dr. Theresa Zesiewicz at the University of South Florida conducted a long-term open label study of ALCAR examining cardiac and neurological measures in adults with FA. Proceeds from the FARA Energy Ball funded this study.

The study has been completed but no results have been published.

https://www.clinicaltrials.gov/study/NCT01921868